Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/02/062979
CTRI/2024/02/062979
Not yet recruiting
Phase 2

Evaluation of efficacy and safety of Polyherbal Unani formulations, Itrifal Shahtara orally and Marham Kharish Jadeed topically in the management of N ?r F ?rsi (Eczema) - NI

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital Ayush

Eligibility Criteria

Inclusion Criteria

  • •Patients who are willing and able to comply with the scheduled visits and treatment plan, laboratory testing and other study procedure and capable of providing a signed informed consent form indicating the subject has been informed of all pertinent aspects of the study.

Exclusion Criteria

  • •1\.Patients with an evidence of clinically significant and uncontrolled systemic illness.
  • •2\.Patients with a current diagnosis of active skin disease (e.g., psoriasis, lupus erythematosus) or skin infection (bacterial, fungal or viral) especially in place of eczema at the same time.
  • •3\. Patients who had been using topical steroids within past 14 days.
  • •4\. Pregnant and lactating women.
  • •5\. Patients who have a known history or clinically relevant allergy, in particular to any component of the study treatment.
  • •6\. Patients unlikely to cooperate with the study protocol.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
Evaluation of efficacy and safety of Polyherbal Unani formulations in the treatment of fungal infection.Health Condition 1: L00-L08- Infections of the skin and subcutaneous tissueHealth Condition 2: L088- Other specified local infections of the skin and subcutaneous tissue
CTRI/2024/02/063170Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital
Not yet recruiting
Phase 2
To Asses efficacy and safety of polyherbal unani formulation In Nazla
CTRI/2023/10/058727State Unani Medical College Himmatganj Prayagraj
Recruiting
Phase 2
Clinical Study to Evaluate the Effect of Polyherbal Unani formulations in Waram-e-lawzatayn Muzmin (Chronic Tonsillitis).
CTRI/2023/09/057524Ministry of Ayush UP
Recruiting
Phase 2
Clinical Study To Evaluate the efficacy of polyherbal Unani formulation in Zukam (Coryza OR Common Cold)
CTRI/2023/08/056975State Unani Medical College
Completed
Phase 2
Clinical Trial of Polyherbal Formulation COVI-RB01 As An Add-On Therapy With Standard of Care In Mild And Moderate Covid-19 Positive PatientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
CTRI/2021/10/037378Alakart Bio Pharma Pvt Ltd130